{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:03:11Z","timestamp":1784779391958,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Second Batch of the Tianshan Talent Cultivation Program for Young Promising Talents","award":["2023TSYCQNTJ0003"],"award-info":[{"award-number":["2023TSYCQNTJ0003"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260435"],"award-info":[{"award-number":["82260435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Special Projects of the Science and Technology Plan of the Xinjiang Uygur Autonomous Region","award":["2022A03011"],"award-info":[{"award-number":["2022A03011"]}]},{"name":"the Science and Technology Innovation Team Project of the Xinjiang Uygur Autonomous Region Science and Technology Department","award":["2023TSYCTD0014"],"award-info":[{"award-number":["2023TSYCTD0014"]}]},{"name":"Shanghai Key Laboratory of Neuro-Ultrasound for Diagnosis and Treatment and Shanghai Institute of Ultrasound in Medicine.","award":["NUS2026013"],"award-info":[{"award-number":["NUS2026013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fungal periprosthetic joint infection remains a challenging complication in revision arthroplasty.\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      (\n                      <jats:italic>C. albicans<\/jats:italic>\n                      ) is among the most frequently reported fungal pathogens, and biofilm formation further limits antifungal efficacy. Tranexamic acid (TXA) is routinely used to reduce perioperative blood loss in arthroplasty and may come into direct contact with antifungal agents within the joint environment. However, whether TXA modifies antifungal activity against\n                      <jats:italic>C. albicans<\/jats:italic>\n                      remains unclear. This study aimed to evaluate the effect of TXA on the in vitro activity of representative antifungal agents against\n                      <jats:italic>C. albicans<\/jats:italic>\n                      under planktonic and established biofilm conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline planktonic MICs for FLC, VRC, CAS, and AMB were 0.75, 0.5, 1, and 0.75\u00a0\u00b5g\/mL, respectively. In the presence of TXA, susceptibility shifts were class-dependent: MICs for VRC and CAS decreased four-fold and two-fold, respectively, while AMB exhibited a two-fold increase and FLC remained unchanged. Established biofilms showed markedly reduced antifungal susceptibility, and TXA further altered the XTT-derived biofilm metabolic inhibition profiles. For FLC, TXA increased peak metabolic inhibition from approximately 50\u201355% in saline to 85\u201390%, with an XTT-derived MBEC\u2089\u2080 of 192\u00a0\u00b5g\/mL. In contrast, TXA attenuated VRC-mediated biofilm metabolic inhibition, producing a right-shifted dose-response profile relative to saline conditions. For CAS, TXA lowered the XTT-derived activity threshold from 256 to 128\u00a0\u00b5g\/mL, although the response curves converged at higher concentrations. For AMB, TXA reduced apparent biofilm activity, increasing the XTT-derived minimum biofilm eradication concentrations (MBECs) threshold from 1.5 to 12\u00a0\u00b5g\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      TXA differentially modulated the apparent in vitro activity of representative antifungal agents against\n                      <jats:italic>C. albicans<\/jats:italic>\n                      in an antifungal class- and growth-state-dependent manner. The discordance between planktonic and antibiofilm responses under TXA co-exposure supports further mechanistic and translational validation in clinically relevant\n                      <jats:italic>Candida<\/jats:italic>\n                      biofilm models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05235-w","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:24:38Z","timestamp":1780107878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of tranexamic acid on planktonic and biofilm susceptibility of Candida albicans"],"prefix":"10.1186","volume":"26","author":[{"given":"Liqin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangde","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"2","key":"5235_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande AJ, Patel R. Prosthetic Joint Infection. Clin Microbiol Rev. 2014;27(2):302\u201345. 10.1128. \/CMR.00111-13 PubMed PMID: 24696437; PubMed Central PMCID: PMC3993098.","journal-title":"Clin Microbiol Rev"},{"issue":"Supplement6","key":"5235_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2106\/JBJS.I.00574","volume":"91","author":"K Azzam","year":"2009","unstructured":"Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B, et al. Microbiological, Clinical, and Surgical Features of Fungal Prosthetic Joint Infections: A Multi-Institutional Experience. J Bone Joint Surg Am. 2009;91(Supplement6):142\u20139. 10.2106. \/JBJS.I.00574 PubMed PMID: 19884422.","journal-title":"J Bone Joint Surg Am"},{"issue":"10016","key":"5235_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736","volume":"387","author":"BH Kapadia","year":"2016","unstructured":"Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016;387(10016):386\u201394. https:\/\/doi.org\/10.1016\/S0140-6736. )61798-0 PubMed PMID: 26135702.","journal-title":"Lancet"},{"issue":"8","key":"5235_CR4","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.arth","volume":"33","author":"TS Brown","year":"2018","unstructured":"Brown TS, Petis SM, Osmon DR, Mabry TM, Berry DJ, Hanssen AD, et al. Periprosthetic Joint Infection With Fungal Pathogens. J Arthroplast. 2018;33(8):2605\u201312. https:\/\/doi.org\/10.1016\/j.arth. 2018.03.003 PubMed PMID: 29636249.","journal-title":"J Arthroplast"},{"issue":"1","key":"5235_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clin Microbiol Rev. 2007;20(1):133\u201363. 10. 1128\/CMR.00029-06 PubMed PMID: 17223626; PubMed Central PMCID: PMC1797637.","journal-title":"Clin Microbiol Rev"},{"key":"5235_CR6","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.bioflm.2023.100126","volume":"5","author":"OH Ajetunmobi","year":"2023","unstructured":"Ajetunmobi OH, Badali H, Romo JA, Ramage G, Lopez-Ribot JL. Antifungal therapy of Candida biofilms: Past, present and future. Biofilm. 2023;5:100126. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100126 . PubMed PMID: 37193227; PubMed Central PMCID: PMC10182175.","journal-title":"Biofilm"},{"issue":"1","key":"5235_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/jcm14010206","volume":"14","author":"W Sznajder","year":"2025","unstructured":"Sznajder W, Jankowska-Pola\u0144ska B, Ta\u0144ski W. A Narrative Review of Fungal Periprosthetic Joint Infections of the Hip and Knee: Risk Factors, Microbiological Profiles, and Treatment Challenges. J Clin Med. 2025;14(1):206. https:\/\/doi.org\/10.3390\/jcm14010206 . PubMed PMID: 39797289; PubMed Central PMCID: PMC11721793.","journal-title":"J Clin Med"},{"issue":"6","key":"5235_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/antibiotics10060711","volume":"10","author":"H Garlito-D\u00edaz","year":"2021","unstructured":"Garlito-D\u00edaz H, Esteban J, Mediero A, Carias-C\u00e1lix RA, Toirac B, Mulero F, et al. A New Antifungal-Loaded Sol-Gel Can Prevent Candida albicans Prosthetic Joint Infection. Antibiotics. 2021;10(6):711. https:\/\/doi.org\/10.3390\/antibiotics10060711 . PubMed PMID: 34204833; PubMed Central PMCID: PMC8231561.","journal-title":"Antibiotics"},{"issue":"6","key":"5235_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0966-842x","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003;11(6):272\u20139. https:\/\/doi.org\/10.1016\/s0966-842x. (03)00117-3 PubMed PMID: 12823944.","journal-title":"Trends Microbiol"},{"issue":"8","key":"5235_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/antibiotics9080445","volume":"9","author":"G Wall","year":"2020","unstructured":"Wall G, Lopez-Ribot JL, Current, Antimycotics. New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics. 2020;9(8):445. doi:10.3390\/antibiotics9080445 PubMed PMID: 32722455; PubMed Central PMCID: PMC7460292.","journal-title":"Antibiotics"},{"issue":"3","key":"5235_CR11","doi-asserted-by":"publisher","first-page":"102856","DOI":"10.1016\/j.otsr.2021.102856","volume":"107","author":"A Klasan","year":"2021","unstructured":"Klasan A, Gerber F, Schermuksnies A, Putnis SE, Neri T, Heyse TJ. Blood loss after revision knee arthroplasty is 1.38- to 2.17-fold higher than after primary knee arthroplasty: A retrospective analysis of 898 cases. Orthop Traumatol Surg Res. 2021;107(3):102856. https:\/\/doi.org\/10.1016\/j.otsr.2021.102856 . PubMed PMID: 33588093.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"7S","key":"5235_CR12","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1016\/j.arth.2018.10.018","volume":"34","author":"E Huerfano","year":"2019","unstructured":"Huerfano E, Huerfano M, Shanaghan KA, Gonzalez Della Valle A. Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated With Earlier Recovery. J Arthroplasty. 2019;34(7S):S249\u201355. https:\/\/doi.org\/10.1016\/j.arth.2018.10.018 . PubMed PMID: 30448325.","journal-title":"J Arthroplasty"},{"key":"5235_CR13","doi-asserted-by":"publisher","unstructured":"Rainey JP, Fillingham YA, Hannon CP. Tranexamic Acid is Safe and Effective in Reducing Blood Loss and Transfusion Rates in Nearly all Patients Undergoing Total Hip and Knee Arthroplasty. Arthroplasty Today. 2025;101868. https:\/\/doi.org\/10.1016\/j.artd.2025.101868.","DOI":"10.1016\/j.artd.2025.101868"},{"key":"5235_CR14","doi-asserted-by":"publisher","first-page":"935646","DOI":"10.3389\/fmicb.2022.935646","volume":"13","author":"A Benjumea","year":"2022","unstructured":"Benjumea A, D\u00edaz-Navarro M, Hafian R, Cercenado E, S\u00e1nchez-Somolinos M, Vaquero J, et al. Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci. Front Microbiol. 2022;13:935646. https:\/\/doi.org\/10.3389\/fmicb.2022.935646 . PubMed PMID: 35847081; PubMed Central PMCID: PMC9280180.","journal-title":"Front Microbiol"},{"key":"5235_CR15","doi-asserted-by":"publisher","first-page":"1367884","DOI":"10.3389\/fmicb.2024.1367884","volume":"15","author":"A Benjumea","year":"2024","unstructured":"Benjumea A, D\u00edaz-Navarro M, Gago-Campos \u00c1S, Visedo A, Hafian R, Cercenado E, et al. Validation of the antibacterial effect of topically applied tranexamic acid using in vitro and in vivo models. Front Microbiol. 2024;15:1367884. https:\/\/doi.org\/10.3389\/fmicb.2024.1367884 . PubMed PMID: 38808275; PubMed Central PMCID: PMC11130467.","journal-title":"Front Microbiol"},{"key":"5235_CR16","doi-asserted-by":"publisher","unstructured":"Yang C, Ji B, Li G, Zhang X, Xu B, Maimaitiyiming A, et al. Weight-Based Tranexamic Acid Is More Effective in Reducing Postoperative Blood Loss Compared to a Fixed-Dose Regimen in Revision Hip Arthroplasty: A Comparative Study. J Arthroplasty. 2025;S0883\u201354032500960\u2013X. https:\/\/doi.org\/10.1016\/j.arth.2025.07.058. PubMed PMID: 40738232.","DOI":"10.1016\/j.arth.2025.07.058"},{"key":"5235_CR17","doi-asserted-by":"publisher","first-page":"111568","DOI":"10.1016\/j.biopha.2021.111568","volume":"139","author":"Y Wang","year":"2021","unstructured":"Wang Y, Lu C, Zhao X, Wang D, Liu Y, Sun S. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans. Biomed Pharmacother. 2021;139:111568. https:\/\/doi.org\/10.1016\/j.biopha.2021.111568 . PubMed PMID: 33845374.","journal-title":"Biomed Pharmacother"},{"key":"5235_CR18","doi-asserted-by":"publisher","first-page":"935646","DOI":"10.3389\/fmicb.2022.935646","volume":"13","author":"A Benjumea","year":"2022","unstructured":"Benjumea A, D\u00edaz-Navarro M, Hafian R, Cercenado E, S\u00e1nchez-Somolinos M, Vaquero J, et al. Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci. Front Microbiol. 2022;13:935646. https:\/\/doi.org\/10.3389\/fmicb.2022.935646 . PubMed PMID: 35847081; PubMed Central PMCID: PMC9280180.","journal-title":"Front Microbiol"},{"issue":"1","key":"5235_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10195-025-00844","volume":"26","author":"C Yang","year":"2025","unstructured":"Yang C, Ji B, Li G, Zhang X, Xu B, Maimaitiming A, et al. Weight-based tranexamic acid lowers the risk of postoperative blood loss and transfusion requirements compared with fixed-dose regimen in revision knee arthroplasty: a comparative study. J Orthop Traumatol. 2025;26(1):26. https:\/\/doi.org\/10.1186\/s10195-025-00844-. z PubMed PMID: 40316735; PubMed Central PMCID: PMC12048371.","journal-title":"J Orthop Traumatol"},{"key":"5235_CR20","doi-asserted-by":"publisher","unstructured":"McLean M, McCall K, Smith IDM, Blyth M, Kitson SM, Crowe L et al. a. N,. Tranexamic acid toxicity in human periarticular tissues. Bone Joint Res. 2019;8(1):11\u20138. https:\/\/doi.org\/10.1302\/2046-3758.81.BJR-2018-0181.R1 PubMed PMID: 30800295; PubMed Central PMCID: PMC6359888.","DOI":"10.1302\/2046-3758.81.BJR-2018-0181.R1"},{"issue":"1","key":"5235_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40001-021-00491-0","volume":"26","author":"X Liu","year":"2021","unstructured":"Liu X, Chen R, Jiang L, Li X, Sun Z. Effect of infusion irrigation with different irrigating solutions on transient receptor potential vanilloid 5 and intra-articular inflammation in a post-traumatic osteoarthritis rabbit model. Eur J Med Res. 2021;26(1):24. https:\/\/doi.org\/10.1186\/s40001-021-00491-0 . PubMed PMID: 33706812; PubMed Central PMCID: PMC7953622.","journal-title":"Eur J Med Res"},{"issue":"9","key":"5235_CR22","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479","volume":"45","author":"G Ramage","year":"2001","unstructured":"Ramage G, Vande Walle K, Wickes BL, L\u00f3pez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475\u20139. https:\/\/doi.org\/10.1128\/AAC.45.9.2475-2479. 2001 PubMed PMID: 11502517; PubMed Central PMCID: PMC90680.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5235_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0966-842x","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003;11(6):272\u20139. https:\/\/doi.org\/10.1016\/s0966-842x. (03)00117-3 PubMed PMID: 12823944.","journal-title":"Trends Microbiol"},{"issue":"6","key":"5235_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/s0966-842x","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003;11(6):272\u20139. https:\/\/doi.org\/10.1016\/s0966-842x. (03)00117-3 PubMed PMID: 12823944.","journal-title":"Trends Microbiol"},{"issue":"10","key":"5235_CR25","doi-asserted-by":"publisher","first-page":"e2006872","DOI":"10.1371\/journal.pbio.2006872","volume":"16","author":"R Zarnowski","year":"2018","unstructured":"Zarnowski R, Sanchez H, Covelli AS, Dominguez E, Jaromin A, Bernhardt J, et al. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 2018;16(10):e2006872. https:\/\/doi.org\/10.1371\/journal.pbio.2006872 . PubMed PMID: 30296253; PubMed Central PMCID: PMC6209495.","journal-title":"PLoS Biol"},{"issue":"2","key":"5235_CR26","first-page":"186","volume":"5","author":"DM Kuhn","year":"2004","unstructured":"Kuhn DM, Ghannoum MA. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs. 2004;5(2):186\u201397. PubMed PMID: 15043393.","journal-title":"Curr Opin Investig Drugs"},{"issue":"6","key":"5235_CR27","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1128\/AAC.03065-15","volume":"60","author":"LJ Marcos-Zambrano","year":"2016","unstructured":"Marcos-Zambrano LJ, G\u00f3mez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species. Antimicrob Agents Chemother. 2016;60(6):3579\u201386. https:\/\/doi.org\/10.1128\/AAC.03065-15 . PubMed PMID: 27021323; PubMed Central PMCID: PMC4879372.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5235_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","volume":"72","author":"PL McCormack","year":"2012","unstructured":"McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585\u2013617. https:\/\/doi.org\/10.2165\/11209070-000000000-00000 . PubMed PMID: 22397329.","journal-title":"Drugs"},{"key":"5235_CR29","doi-asserted-by":"publisher","first-page":"935646","DOI":"10.3389\/fmicb.2022.935646","volume":"13","author":"A Benjumea","year":"2022","unstructured":"Benjumea A, D\u00edaz-Navarro M, Hafian R, Cercenado E, S\u00e1nchez-Somolinos M, Vaquero J, et al. Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci. Front Microbiol. 2022;13:935646. https:\/\/doi.org\/10.3389\/fmicb.2022.935646 . PubMed PMID: 35847081; PubMed Central PMCID: PMC9280180.","journal-title":"Front Microbiol"},{"key":"5235_CR30","doi-asserted-by":"publisher","first-page":"1367884","DOI":"10.3389\/fmicb.2024.1367884","volume":"15","author":"A Benjumea","year":"2024","unstructured":"Benjumea A, D\u00edaz-Navarro M, Gago-Campos \u00c1S, Visedo A, Hafian R, Cercenado E, et al. Validation of the antibacterial effect of topically applied tranexamic acid using in vitro and in vivo models. Front Microbiol. 2024;15:1367884. https:\/\/doi.org\/10.3389\/fmicb.2024.1367884 . PubMed PMID: 38808275; PubMed Central PMCID: PMC11130467.","journal-title":"Front Microbiol"},{"key":"5235_CR31","doi-asserted-by":"publisher","first-page":"153223","DOI":"10.1016\/j.phymed.2020.153223","volume":"71","author":"F Mo","year":"2020","unstructured":"Mo F, Ma J, Yang X, Zhang P, Li Q, Zhang J. In vitro and in vivo effects of the combination of myricetin and miconazole nitrate incorporated to thermosensitive hydrogels, on C. albicans biofilms. Phytomedicine. 2020;71:153223. https:\/\/doi.org\/10.1016\/j.phymed.2020.153223 . PubMed PMID: 32460204.","journal-title":"Phytomedicine"},{"issue":"8","key":"5235_CR32","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/microorganisms13081874","volume":"13","author":"M D\u00edaz-Navarro","year":"2025","unstructured":"D\u00edaz-Navarro M, Benjumea A, Visedo A, Mu\u00f1oz P, Vaquero J, Chana F, et al. Quantification and Comparison of Different Biofilm Components from Methicillin-Susceptible Staphylococcus aureus Treated with Tranexamic Acid Using an In Vitro Model. Microorganisms. 2025;13(8):1874. https:\/\/doi.org\/10.3390\/microorganisms13081874 . PubMed PMID: 40871378; PubMed Central PMCID: PMC12388762.","journal-title":"Microorganisms"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05235-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05235-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05235-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:18:06Z","timestamp":1784776686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05235-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5235"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05235-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study was an in vitro microbiological investigation and did not involve human participants, human data, human tissue, or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"661"}}